Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1975 Aug;8(2):216–219. doi: 10.1128/aac.8.2.216

Antibacterial Activity of Nitropyrroles, Nitrothiophenes, and Aminothiophenes In Vitro

Ching Y Wang 1, Chung W Chiu 1, Keiji Muraoka 1, Preston D Michie 1, George T Bryan 1
PMCID: PMC429290  PMID: 810079

Abstract

The antibacterial activities of nitropyrroles, nitrothiophenes, and aminothiophenes were studied. Replacement of the nitro group with an amino group enhanced the activity of the thiophene compounds.

Full text

PDF
216

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASNIS R. E. The reduction of Furacin by cell-free extracts of Furacin-resistant and parent-susceptible strains of Escherichia coli. Arch Biochem Biophys. 1957 Jan;66(1):208–216. doi: 10.1016/0003-9861(57)90551-9. [DOI] [PubMed] [Google Scholar]
  2. Cohen S. M., Lower G. M., Jr, Ertürk E., Bryan G. T. Comparative carcinogenicity in Swiss mice of N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide and structurally related 5-nitrofurans and 4-nitrobenzenes. Cancer Res. 1973 Jul;33(7):1593–1597. [PubMed] [Google Scholar]
  3. Colwell W. T., Lange J. H., Henry D. W. Chemotherapeutic nitroheterocycles. Nitropyrrole-2-carboxaldehyde derivatives. J Med Chem. 1968 Mar;11(2):282–285. doi: 10.1021/jm00308a021. [DOI] [PubMed] [Google Scholar]
  4. EBETINO F. F., CARROLL J. J., GEVER G. REDUCTION OF NITROFURANS. I. AMINOFURANS. J Med Pharm Chem. 1962 May;91:513–524. doi: 10.1021/jm01238a011. [DOI] [PubMed] [Google Scholar]
  5. Feller D. R., Morita M., Gillette J. R. Enzymatic reduction of niridazole by rat liver microsomes. Biochem Pharmacol. 1971 Jan;20(1):203–215. doi: 10.1016/0006-2952(71)90486-2. [DOI] [PubMed] [Google Scholar]
  6. Grunberg E., Titsworth E. H. Chemotherapeutic properties of heterocyclic compounds: monocyclic compounds with five-membered rings. Annu Rev Microbiol. 1973;27:317–346. doi: 10.1146/annurev.mi.27.100173.001533. [DOI] [PubMed] [Google Scholar]
  7. McCalla D. R., Reuvers A., Kaiser C. Mode of action of nitrofurazone. J Bacteriol. 1970 Dec;104(3):1126–1134. doi: 10.1128/jb.104.3.1126-1134.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Miura K., Reckendorf H. K. The nitrofurans. Prog Med Chem. 1967;5:320–381. doi: 10.1016/s0079-6468(08)70446-6. [DOI] [PubMed] [Google Scholar]
  9. TAYLOR J. D., PAUL H. E., PAUL M. F. Metabolism of the nitrofurans. III. Studies with xanthine oxidase in vitro. J Biol Chem. 1951 Jul;191(1):223–231. [PubMed] [Google Scholar]
  10. Yahagi T., Nagao M., Hara K., Matsushima T., Sugimura T., Bryan G. T. Relationships between the carcinogenic and mutagenic or DNA-modifying effects of nitrofuran derivatives, including 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide, a food additive. Cancer Res. 1974 Sep;34(9):2266–2273. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES